IRB Directors' Perceptions of Proposed Revisions to the Regulations for Protecting Human Subjects
Issue Date
2011-12-31Author
McDowell, Ryan
Publisher
University of Kansas
Format
59 pages
Type
Thesis
Degree Level
M.S.
Discipline
Clinical Research
Rights
This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
Metadata
Show full item recordAbstract
In July, the U.S. Department of Health and Human Services (HHS), in association with the Office of Human Research Protections (OHRP) and the Food and Drug Administration (FDA), issued an Advance Notice of Proposed Rulemaking focused on modernizing the federal regulations for the protection of human subjects. Three areas targeted for revisions would have a substantial effect on how IRBs review human subjects research: ensuring risk-based protections, streamlining IRB review of multi-site studies and improving informed consent. The current study aimed to assess IRB Directors' perceptions of these proposed revisions and identify any barriers to implementation. The results of the study showed that IRB Directors agree that the federal regulations need to be updated and generally agree with the proposed revisions regarding mandating singe IRB review of multi-site studies and efforts to improve the length and complexity of informed consent forms. However, subjects did not agree with the proposed changes in regards to the new "excused" category, specifically the concept of allowing investigators to register studies with the IRB opposed to submitting for IRB review and approval prior to commencing research activities.
Collections
- KU Med Center Dissertations and Theses [464]
- Theses [3943]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.